chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I got the flu; Initial information received on 27-Jan-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-healthcare professional (hcp).  This case involves a patient (age, gender: unknown) who got the flu while receiving vaccine INFLUENZA VACCINE.  It is unknown if the patient had any medical history, concomitant disease or risk factor. It is unknown if there were lab data/results available.  On an unknown date, the patient received an unknown dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (strength, formulation: unknown) (lot number not reported) via unknown route in unknown administration site for prophylactic vaccination. Information on the batch number was requested.  On an unknown date the patient developed a non-serious event " got the flu (influenza)" (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported, "This case is received from Social media. The following potential adverse event has been found on a public post for social media page. Since this is a public post on the flu shot campaign, we are assuming the consumer is referring to the Sanofi flu vaccine. I got a flu shot , got the flu a week later, Next year I tried it again a year later, Yep a week later I got the flu. NEVER AGAIN!!! I refuse the covid vaccine. I tested positive for the cooties. I got my test, I got the test on a Tue, they said 3-5 days to get results. I had it back (positive) the next day. It is unknown if the patient experienced any additional symptoms/events".   Relevant laboratory test results included: Laboratory test - On an unknown date: positive [tested positive for the cooties]  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (I got the flu).  At time of reporting, the outcome was Unknown for the event i got the flu.
He states that they are not sure if a geriatric patient received an expired 2nd Monovalent dose of Moderna vaccine beyond MFG expiration date.; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (He states that they are not sure if a geriatric patient received an expired 2nd Monovalent dose of Moderna vaccine beyond MFG expiration date.) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (He states that they are not sure if a geriatric patient received an expired 2nd Monovalent dose of Moderna vaccine beyond MFG expiration date.) and NO ADVERSE EVENT (No adverse event). At the time of the report, CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (He states that they are not sure if a geriatric patient received an expired 2nd Monovalent dose of Moderna vaccine beyond MFG expiration date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (He states that they are not sure if a geriatric patient received an expired 2nd Monovalent dose of Moderna vaccine beyond MFG expiration date).    Concomitant medication was not provided. Treatment information was not reported.   Reporter did not allow further contact
11-1-11 vaccinated. 11-2-11 went to E.D Dx: cellulitis Tx: clindamycin. 11-3-11 appt at health center, mom reports fever, redness, lump. 11-4-11 appt at health center. Fever persist 101.4 degrees, erythema worse. Sent to E.D. Admitted Tx: IV vancomycin. 11/8/11 f/u visit at health center normal, healthy child.
This case was reported by a physician via sales rep and described the occurrence of pain in arm in a male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, unknown after receiving SHINGRIX, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, when the patient received SHINGRIX, his arm hurt for weeks. The patient had recovered after some weeks. This case has been linked with case US2019GSK065527, reported by the same reporter.
Information has been received from a physician concerning a 40 year old female with metabolic syndrome, high cholesterol, increased blood sugar, rheumatoid arthritis and asthma who on 01-OCT-2007 was inadvertently vaccinated with Gardasil. Concomitant therapy included lansoprazole (PREVACID), cyclobenzaprine hydrochloride (MSD), montelukast sodium (MSD), valsartan (DIOVAN), gabapentin (NEURONTIN), metformin, "Clonazapen" (therapy unspecified), desloratadine (CLARINEX), ranitidine HCl (ZANTAC), potassium (unspecified), fluticasone propionate 9+) salmeterol xinafoate (ADVAIR), albuterol, ipratropium bromide (ATROVENT) and alprazolam (XANAX). The physician reported that 30 minutes after the patient was vaccinated she experienced angioedema, reddness in her face, and a tightening in her throat. Since the patient was vaccinated, she frequented many emergency rooms and was admitted to the hospital for 2 days. The patient was treated with prednisone, diphenhydramine hydrochloride (Benadryl) and methylprednisolone acetate (Depo-medrol) and subsequently was recovering from the events. The physician believed that her symptoms were reflux due to the many medications that the patient was taking. The angioedema, reddness in face, tightening in throat, reflux and wrong drug administered were considered other important medical events. Additional information has been requested.
Information has been received from a medical assistant concerning a male patient with no known medical history who was vaccinated with pneumococcal 23v polysaccharide vaccine (Lot #658555/0964U). The patient developed redness and inflammation at the injection site. The symptoms appeared either one or two days after the vaccination. It was reported that three patients all received the same vaccination, two females and one male, all from the same lot number and they all developed redness and inflammation. Only one of the three patients recovered from the symptoms. The other two patients are either recovering or unknown. One patient received the flu vaccine along with pneumococcal 23v polysaccharide vaccine (Lot #658555/0964) on a different arm. No further information is available. Additional information has been requested.
Patient stated had many allergies and sensitivities. Vaccinator had her wait 30 minutes instead of 15 minutes.  Patient came up to nurse and stated she called her doctor to tell him she had shortness of breath.  Patient instructed to notify us by her physician. Took to ER
Friday night, I had flu like symptoms - those resolved by Saturday morning; Saturday night - I had a tickle in my throat - it is the best I can describe. That went on through Sunday - tickle throat - because I have allergies, I didn't know. Tickle in my throat - Monday when I was heading to work, I called our medical director and told him I was on the way to work he told me I had to go get tested for COVID. I went to go test - I got sinus stuff - Tuesday morning, my test was Positive test. I did isolate. Because I was asthmatic I went into Panic mode - called dr and got on a Z pack - took my prednisone and took my inhaler - I was out of work for 10-14 days for the isolation. The tickle resolved - and I was left with just a slight cough - I would have days when it was worse than others - because of my asthma and anxiety, it would get worse, I think. No fever, no chills, no body aches.   2nd dose -only  lasted 24 hours - and I had the usual normal symptoms - very much with body aches, fever chills etc.
Client informed RN that got dizzy 3-4hrs after Pfizer dose 2. She got dizzy for about an hr. Client didn?t seek emergency care, or primary care provider. She took no meds. Client states she?s gotten dizzy before due to menopause, and vertigo, that hasn?t been diagnosed. Client didn?t think much of it. The following day she felt weakness and mild dizziness that went away. Client has no allergies. No other medical conditions. A medical consult was submitted by RN to Clinical Project Coordinator. Client received approval to receive Pfizer COVID vaccine Booster by MD. Client received Pfizer Booster Lot # FK9896. Client reported no symptoms while waiting in observation area for 15mins. Client left vaccination area in steady gait.
Headache, Myalgia, Fever, Diarrhea, Pain to left arm, Fatigue, Photophobia Narrative:  Other Relevant History:
This spontaneous report as received from a nurse practitioner refers to a patients of unknown age and gender. On an unknown date the patients were vaccinated with (Oka/Merck) VARIVAX (dose, lot # not reported) which was improperly stored. The outcome of clients vaccinated with improperly stored (Oka/Merck) VARIVAX was unknown. Additional information is not expected because there is no possibility to contact physician.
Immunizations administered at health department.  Mother states 2 hours after vaccines child began with fever.  Fever reaching 104 degrees F.  Fever remained with Ibuprofen.  On 5/28/04 child was taken to PMD for complaint of fever.  Later on 5/28/04 mother states child had a seizure requiring him to visit local ER.  Hospital record states that child had history of seizures.  ER discharge report stated two diagnoses:  febrile seizure and pharyngitis Follow Up: Recommendation made by physician reviewer to complete DTaP series with DT only.
At 7pm, patient was cooking and described difficulty breathing and wheezing. She went to lay down and at 10pm woke with chills, shaking and aching. At 10:30pm she had as she describes one violent episode of vomiting but went back to bed with continued aches and chilles. She woke the next morning drenched in sweat but felt much better.
Tested positive for COVID; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for COVID) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for COVID) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Prevnar injection given R upper thigh on 8/6/07. Mother noticed swelling on 8/6/07. Brought to clinic 8/8/07 with redness, warm to touch and swelling.
Noticed arm injections were both given in (used same arm for both DTAP and Meningiococcal) Arm was hard, swollen, red, painful, & warm. Noticed worsening of attention, more angry. Seemed Aspergers symptoms were worse, and continue today. Reported to MD. Was told to use compresses. Not to worry about it. Did have 2 follow up visits to make sure condition resolved.
11:40am - received 2nd Moderna vaccine at Vaccination Superstation 3:00pm - started to feel queasy (this was also felt with first vaccine) 5:00pm - ate dinner 11:00pm, 2:00am, and 6:00am - vomited 7:00am - tried a small piece of toast for breakfast 9:00am - vomited and immediately had to defecate, while on toilet started to feel dizzy, got up to walk to bed and collapsed on my way, blacked out for a few seconds and hit my face on the carpet.  Husband was nearby, he helped me turn over onto my back, I laid there for about 30 minutes resting and then called nurse line who recommended I go to ER.  Arrived at ER around 10am.  While in waiting room at ER, began to feel dizzy, nurse immediately checked BP and it was low, brought me to room to lay down.  Started IV fluids.  Doctor consulted, suggested it was likely a vasovagal syncope episode.    Ran EKG, CT scan, urinalysis, CBC, chest and finger radiographs- all normal.   Received 2 bags of LRS fluids and was able to eat some crackers, discharged around 3pm.  I was tired and nauseous the rest of the day but was able to eat small amounts of bland food.  No further vomiting.  The next day, 2/14, I was still tired and nauseous but ate small meals and rested a lot.  Today, 2/15, feeling stronger but not 100%, still a little bit queasy but better than I've been the last few days.
I had a Sore throat and what felt like a sinus infection. 4/28/2022 symptoms started, 4/29 tested on board, 4/30 positive test result. I experienced the back of the neck sweating continuously for about 4 days, coughing as well, though it comes and goes.
Mild fever; Kept me awake; Mild arm soreness; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 36-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE, Solution for injection, Lot Number: EL3248, Expiry date: unknown) intramuscular route of administration, administered in left arm on 10Mar2021 09:15 (age at vaccination: 36-Year-old) as dose 2, single for COVID-19 immunization (Workplace clinic). The patient medical history and concomitant medications were not reported. Not received any other vaccine in four weeks prior to vaccination. Patient had not tested for covid, prior and post vaccination. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE, Solution for injection, Lot Number: EL3247, Expiry date: unknown) via intramuscularly, administered in left arm on 19Feb2021 10:00 as dose 1, single for COVID-19 immunization. On 11Mar2021 at 03:00, the patient experienced mild fever (18-22 hours after injection), kept me awake and mild arm soreness. Did not take drugs to counteract. The patient had not received any treatments for the events. The outcome of the events was recovered on unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Late in the day of vaccination developed swelling, pain and tenderness of the injection site, along with malaise, generalized muscle pain, dizziness and tenderness and headache.  Day 2 - Worse and moderately severe the next day, both arm and generalized symptoms.   Unable to work, mostly in bed.  Treated with Naproxen and Acetaminophen with mild to moderate benefit.  Day 3 - Getting better. Up around the house. Still taking Naproxen/Acetaminophen.  Day 4 - Nearly back to normal.  Back to work.  Day 5 - Resolved.
No adverse event; they had the Spikevax 2023-2024 single dose vials stored in the freezer that experienced a temperature excursion yesterday morning for 15 minutes; Patient received Spikevax 2023-2024 single dose vials stored in the freezer that experienced a temperature excursion for 15 minutes; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (they had the Spikevax 2023-2024 single dose vials stored in the freezer that experienced a temperature excursion yesterday morning for 15 minutes), POOR QUALITY PRODUCT ADMINISTERED (Patient received Spikevax 2023-2024 single dose vials stored in the freezer that experienced a temperature excursion for 15 minutes) and NO ADVERSE EVENT (No adverse event) in an adolescent patient of an unknown gender who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. 8057456) for COVID-19 prophylaxis.     No Medical History information was reported.    On 25-Sep-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On 25-Sep-2023, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (they had the Spikevax 2023-2024 single dose vials stored in the freezer that experienced a temperature excursion yesterday morning for 15 minutes) and POOR QUALITY PRODUCT ADMINISTERED (Patient received Spikevax 2023-2024 single dose vials stored in the freezer that experienced a temperature excursion for 15 minutes). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (they had the Spikevax 2023-2024 single dose vials stored in the freezer that experienced a temperature excursion yesterday morning for 15 minutes), POOR QUALITY PRODUCT ADMINISTERED (Patient received Spikevax 2023-2024 single dose vials stored in the freezer that experienced a temperature excursion for 15 minutes) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (they had the Spikevax 2023-2024 single dose vials stored in the freezer that experienced a temperature excursion yesterday morning for 15 minutes) and POOR QUALITY PRODUCT ADMINISTERED (Patient received Spikevax 2023-2024 single dose vials stored in the freezer that experienced a temperature excursion for 15 minutes).    Concomitant medications were not reported.  None of the patients have reported any adverse reactions at this time.  Treatment medications were not reported.  This case contains information for patient 05 out of 06.   This case was linked to US-MODERNATX, INC.-MOD-2023-742028 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-742028:Patient 5 out of 6
This spontaneous report was received from a clinic manager (also reported as "healthcare professional") regarding a patient of an unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On an 15-JAN-2019, the patient was vaccinated with a dose of M-M-R II (dose, frequency, and route of administration were not provided, Lot # M045393, expiration date: 14-NOV-2018) for prophylaxis reconstituted with sterile diluent (lot # M019899, expiration date: 22-OCT-2018) that was expired. No adverse effect was reported.
This case was reported by a healthcare professional and described the occurrence of arm pain in a female subject aged between 40 and 49 year old who was vaccinated with FLULAVAL (GlaxoSmithKline).  On 08 September 2008, the subject received unspecified dose of FLULAVAL (.5 unknown, unknown).  At an unspecified time after vaccination with FLULAVAL, the subject experienced severe arm pain and presented to the emergency room for treatment, where she was prescribed prednisone at 40 mg for five days, vicodin and antibiotics.  The subject was seen for follow-up at the physician's office on 15 September 2008, when she informed the reporting nurse of the event.  The subject told the nurse that she did not know why she was prescribed the antibiotics.  At the time of reporting, the event was improved.  The healthcare professional considered the event was probably related to vaccination with FLULAVAL.  Follow-up information received on 07 October 2008 indicated that the subject was 40 year old at the time of events.  FLULAVAL was administered in an unknown arm.  On 12 September 2008, the subject experience arm pain and had swelling.  She was treated with Prednisone, Vicodin and Keflex.  The events resolved. In the reporter's opinion, the events were possibly related to treatment with FLULAVAL.
When I stand up I almost pass out.  Nose is constantly stuffed up and running and muscle spasms and heart murmurs.  Muscle and joint aches and stiffness.   This is all the time now 24/7.
R elbow and forearm itching red rash lasting up to 2 1/2 weeks, also itching red rash on R elbow one week later.  Both releaved with Benadryl. Night of vaccine administration, woke sweating as if fever broke.
The second day toward the evening I had an elevated heart rate for most of the night.  The worst symptom and that I had a feeling  like I had a sun burn on the lower part of my face with a burning sensation. It went away after an hour but come back in  all the parts of my upper body, My neck, arms and back that that burning sensation feeling. It felt like I had a sunburn and laid down on a warm heating pack. The heat was just so uncomfortable. My nose was red and my ears too, I could feel heat coming from my nostrils but I never had a fever. I checked my temperature several times throughout this experience. I also felt extreme thirst and I  kept drinking water constantly.  This heating sensation kept me from sleeping , in a two day period I had gotten maybe  6 hours of combined sleep. This burning sensation started on my lower face (cheeks) about  30 hours after I received my vaccine. It started to feel better Thursday morning, which was  3 days after my vaccination.  I have not had any rashes, hives or skin issues, it was just internal heat without a fever.
This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Received knee brace to help with knee pain) and PAIN IN EXTREMITY (Pain in right leg) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Rheumatoid arthritis. No Medical History information was reported. On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) UNK, Citrate Free. On an unknown date, the patient experienced ARTHRALGIA (Received knee brace to help with knee pain) and PAIN IN EXTREMITY (Pain in right leg). At the time of the report, ARTHRALGIA (Received knee brace to help with knee pain) was resolving and PAIN IN EXTREMITY (Pain in right leg) outcome was unknown. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in. No concomitant medication was reported. It was unknown if patient was enrolled in a COVID-19 Vaccine trial. No treatment medication was reported. The reporter's causality for the event received knee brace to help with knee pain was not provided. The reporter's causality for the event of pain in right leg with Humira was no reasonable possibility. Most recent FOLLOW-UP information incorporated above includes: On 11-Apr-2022: Live follow up information was added. Event information was updated, narrative was updated.
Tested positive for COVID; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 10Feb2021 at single dose for covid-19 immunisation administered at Hospital. The patient medical history and concomitant medications were not reported. The patient reported, he was vaccinated on 10 Feb 2021 and tested positive via a Rapid Antigen test yesterday, 17 Feb 2021. Confirmed as tested positive for COVID. He stated patient is in between the two doses. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The outcome of the event was unknown.
11/11/2001-Seven weeks into her pregnancy, the patient had a spontaneous abortion.